Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.IJANTIMICAG.2006.11.007PMID 17303392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basis for the Management of Drug-Resistant Helicobacter pylori Infection

  2012cited by this paper
• Third-line rescue therapy for Helicobacter pylori infection.

  2006cited by this paper
• Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

  2006cited by this paper
• Gatifloxacin Resistance and Mutations in gyrA after Unsuccessful Helicobacter pylori Eradication in Japan

  2006cited by this paper
• Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients.

  2006cited by this paper
• Moxifloxacin‐based strategies for first‐line treatment of Helicobacter pylori infection

  2005cited by this paper
• Primary and secondary treatment for Helicobacter pylori in the United States.

  2005cited by this paper
• Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

  2005cited by this paper
• Rapid Detection of Point Mutations in the gyrA Gene of Helicobacter pylori Conferring Resistance to Ciprofloxacin by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Approach

  2004cited by this paper
• Role of Topoisomerase Mutations and Efflux in Fluoroquinolone Resistance of Bacteroides fragilis Clinical Isolates and Laboratory Mutants

  2004cited by this paper
• Dystrophic breast calcifications in patients with collagen diseases.

  2004cited by this paper
• In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children.

  2004cited by this paper
• Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South Korea

  2004cited by this paper
• Susceptibilities to Different Antibiotics of Helicobacter pylori Strains Isolated from Patients at the Pediatric Medical Center of Tehran, Iran

  2004cited by this paper
• Efficacy of Two Rabeprazole/Gatifloxacin‐Based Triple Therapies for Helicobacter pylori Infection

  2004cited by this paper
• MECHANISMS OF QUINOLONE RESISTANCE

  2003cited by this paper
• Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori

  2003cited by this paper
• Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

  2002cited by this paper
• A new evolutionary scenario for the Mycobacterium tuberculosis complex

  2002cited by this paper
• Interaction between DNA Gyrase and Quinolones: Effects of Alanine Mutations at GyrA Subunit Residues Ser83and Asp87

  2001cited by this paper
• European Multicentre Survey of in Vitro Antimicrobial Resistance in Helicobacter pylori

  2001cited by this paper
• Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

  2001cited by this paper
• Spontaneous Mutations That Confer Antibiotic Resistance inHelicobacter pylori

  2001cited by this paper
• Helicobacter pylori Uptake and Efflux: Basis for Intrinsic Susceptibility to Antibiotics In Vitro

  2000cited by this paper
• Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones.

  2000cited by this paper
• Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

  2000cited by this paper
• Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

  1999cited by this paper
• Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome

  1998cited by this paper
• Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in Mycobacteria

  1998cited by this paper
• The complete genome sequence of the gastric pathogen Helicobacter pylori

  1997cited by this paper
• A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics

  1997cited by this paper
• Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

  1997cited by this paper
• Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.

  1997cited by this paper
• Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

  1995cited by this paper
• Quinolone antimicrobial agents

  1993cited by this paper
• Manual of clinical microbiology

  1975cited by this paper

• Fabricating streptavidin-embedded metal-organic frameworks for noninvasive gene detection of Helicobacter pylori infection.

  2025cites this paper
• Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective

  2025cites this paper
• Alginate/Polyethylene glycol diacrylate shape memory hydrogel films for gastric retention and antibiotic delivery in H. pylori infection

  2025cites this paper
• Whole genome sequence analysis of Helicobacter pylori isolates reveals incomplete characterization of antimicrobial resistance mechanisms

  2025cites this paper
• Molecular Characterization of Antimicrobial Resistance and Virulence Genotyping among Helicobacter pylori-Positive Dyspeptic Patients in North Iran.

  2024cites this paper
• Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence factors

  2024cites this paper
• In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.

  2024cites this paper
• Bibliometric analysis of Helicobacter pylori resistance—from 2002 to 2022

  2023cites this paper
• Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments

  2023cites this paper
• Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptibility‐guided therapy

  2023cites this paper
• Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice

  2023cites this paper
• Correlation Analysis Among Genotype Resistance, Phenotype Resistance, and Eradication Effect After Resistance-Guided Quadruple Therapies in Refractory Helicobacter pylori Infections

  2022cites this paper
• Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations

  2021cites this paper
• Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study

  2021cites this paper
• Prevalence of Helicobacter pylori Antimicrobial Resistance Among Patients Recruited in Endoscopy Units in Santiago, Chile.

  2021cites this paper
• Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population

  2021cites this paper
• Genetic Antibiotic Resistance of Helicobacter pylori in South-Eastern Romania.

  2020cites this paper
• Genomic Analysis of Antimicrobial Resistance Genotype-to-Phenotype Agreement in Helicobacter pylori

  2020cites this paper
• Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.

  2020cites this paper
• Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin

  2020cites this paper
• Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing

  2020cites this paper
• High prevalence of antibiotic resistance in Helicobacter pylori isolates from Iran: importance of functional and mutational analysis of resistance genes and virulence genotyping

  2019cites this paper
• Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori

  2019cites this paper
• High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients

  2019cites this paper
• New insights into resistance of Helicobacter pylori against third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations

  2019cites this paper
• High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping

  2019cites this paper
• Mutational Analysis of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori from Gastric Biopsy Specimens in a Tertiary Care Hospital in Dhaka, Bangladesh

  2019cites this paper
• Simultaneous detection of human CYP2C19 polymorphisms and antibiotic resistance of Helicobacter pylori using a personalised diagnosis kit.

  2018cites this paper
• Der Einfluss Plasmid-vermittelter Chinolon-Resistenzmechanismen (PMQR) auf die Entstehung klinischer Fluorchinolon-Resistenz

  2018cites this paper
• Helicobacter pylori therapy and clinical perspective.

  2018cites this paper
• Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori.

  2017cites this paper
• Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance

  2017cites this paper
• Advances in diagnosis and treatment of Helicobacter pylori infection.

  2017cites this paper
• Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection

  2017cites this paper
• Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection

  2017cites this paper
• Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool

  2017cites this paper
• Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection

  2017cites this paper
• Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection

  2017cites this paper
• Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014)

  2016cites this paper
• High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea

  2016cites this paper
• Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection

  2016cites this paper
• Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.

  2016cites this paper
• Résistance de Helicobacter pylori aux antibiotiques et d’autres substances antimicrobiennes. : Aspects moléculaires des mécanismes de détection

  2016cites this paper
• Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem

  2016cites this paper
• Eradication of Helicobacter pylori Infection

  2016cites this paper
• Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA.

  2015cites this paper
• Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.

  2015cites this paper
• Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance.

  2015cites this paper
• Review article: the global emergence of Helicobacter pylori antibiotic resistance

  2015cites this paper
• Fluoroquinolone-based protocols for eradication of Helicobacter pylori.

  2014cites this paper
• Treatment of Helicobacter pylori infection: current status and future concepts.

  2014cites this paper
• Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

  2014cites this paper
• The Evolution of Helicobacter Pylori Antibiotics Resistance Over 10 Years in Greece

  2014cites this paper
• Resistotype of Helicobacter pylori isolates: the impact on eradication outcome.

  2014cites this paper
• Nuevas estrategias terapéuticas en la infección por Helicobacter pylori

  2013cites this paper
• Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients

  2013cites this paper
• Randomized study comparing standard first line 10 day therapy against Helicobacter pylori including clarithromycin versus standard first line therapy with levofloxacin

  2013influential citation
• PRIMARY ANTIMICROBIAL RESISTANCE OF HELICOBACTER PYLORI IN BELGIUM

  2013cites this paper
• CARTA DE AUTORIZACIÓN DE LOS AUTORES (Licencia de uso)

  2013cites this paper
• Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.

  2012cites this paper
• Genome‐wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli

  2012cites this paper
• Revised french recommendations on the management of Helicobacter pylori infection

  2012cites this paper
• Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.

  2012cites this paper
• Rescue Therapy for Helicobacter pylori Infection 2012

  2012cites this paper
• High‐dose rabeprazole–amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures

  2012cites this paper
• Quinolones : de l’antibiogramme aux phénotypes de résistance

  2012cites this paper
• Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran

  2012cites this paper
• Gemifloxacin Can Partially Overcome Quinolone Resistance of H. pylori with gyrA Mutation in Taiwan

  2012cites this paper
• Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain.

  2012cites this paper
• [Current value of quinolones in Helicobacter pylori therapy].

  2011cites this paper
• Should quinolones come first in Helicobacter pylori therapy?

  2011cites this paper
• Levofloxacin Susceptibility Testing for Helicobacter pylori in China: Comparison of E‐Test and Disk Diffusion Method

  2011cites this paper
• Distribution of Spontaneous gyrA Mutations in 97 Fluoroquinolone-Resistant Helicobacter pylori Isolates Collected in France

  2011influential citation
• Quand rechercher Helicobacter pylori et comment l’éradiquer: techniques de recherche, traitements, vérification de l’éradication

  2011cites this paper
• High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia

  2011cites this paper
• Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.

  2011cites this paper
• Effectiveness and Safety of Repeated Quadruple Therapy in Helicobacter pylori Infection After Failure of Second‐line Quadruple Therapy

  2011cites this paper
• Estudio de la resistencia de Helicobacter pylori a los antimicrobianos e implicaciones en las terapias de erradicación

  2011influential citation
• Aktueller Stellenwert von Fluorchinolonen in der Helicobacter-pylori-Therapie

  2011cites this paper
• Données actuelles sur la prise en charge de l’infection par Helicobacter pylori

  2010cites this paper
• Genotypic Resistance in Helicobacter pylori Strains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies

  2010cites this paper
• outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial

  2010cites this paper
• Epidemiological Study of Contributing Factors in the Development of Peptic Ulcer and Gastric Cancer Initiated by Helicobacter Pylori Infection in India

  2010cites this paper
• In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998–2007

  2010cites this paper
• Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.

  2010cites this paper
• Efficacy of 1‐week proton pump inhibitor triple therapy as first‐line Helicobacter pylori eradication regime in Asian patients: Is it still effective 10 years on?

  2010cites this paper
• Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial

  2010cites this paper
• Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia.

  2010cites this paper
• Phenotypic and Genetic Characterization of Antimicrobial Profiles of Helicobacter pylori Strains in Cuba

  2010cites this paper
• Helicobacter pylori: Current treatment An important challenge for gastroenterology

  2009cites this paper
• Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin‐based therapy in Taiwan

  2009cites this paper
• Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori

  2009cites this paper
• Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009

  2009cites this paper
• Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK.

  2009influential citation
• Clarithromycin–Amoxycillin‐Containing Triple Therapy: A Valid Empirical First‐Line Treatment for Helicobacter pylori Eradication in Hong Kong?

  2009cites this paper
• Resistencia bacteriana del Helicobacter pylori en el mundo en el año 2009

  2009cites this paper
• REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY

  2009cites this paper
• Helicobacter pylori: Tratamiento actual. Un importante reto en gastroenterología

  2009cites this paper
• Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects.

  2009cites this paper
• Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.

  2009cites this paper